172 related articles for article (PubMed ID: 31892859)
21. A risk score system based on a six-microRNA signature predicts the overall survival of patients with ovarian cancer.
Zhou M; Wu T; Yuan Y; Dong SJ; Zhang ZM; Wang Y; Wang J
J Ovarian Res; 2022 May; 15(1):54. PubMed ID: 35513874
[TBL] [Abstract][Full Text] [Related]
22. Exosomal hsa-miR-129-2 and hsa-miR-889 from a 6-microRNA Signature Might be a Potential Biomarker for Predicting the Prognosis of Papillary Thyroid Carcinoma.
Xin Y; Meng K; Guo H; Chen B; Zheng C; Shou X; Yu K
Comb Chem High Throughput Screen; 2022; 25(5):819-830. PubMed ID: 33550967
[TBL] [Abstract][Full Text] [Related]
23. Bioinformatics Analysis of Prognostic miRNA Signature and Potential Critical Genes in Colon Cancer.
Chen W; Gao C; Liu Y; Wen Y; Hong X; Huang Z
Front Genet; 2020; 11():478. PubMed ID: 32582275
[TBL] [Abstract][Full Text] [Related]
24. A microRNA expression signature as a predictor of survival for colon adenocarcinoma.
Xu M; Kuang Y; Wang M; Han X; Yang Q
Neoplasma; 2017; 64(1):56-64. PubMed ID: 27881005
[TBL] [Abstract][Full Text] [Related]
25. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
Zeng Y; Wang KX; Xu H; Hong Y
J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
[TBL] [Abstract][Full Text] [Related]
26. Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.
Sun M; Song H; Wang S; Zhang C; Zheng L; Chen F; Shi D; Chen Y; Yang C; Xiang Z; Liu Q; Wei C; Xiong B
J Hematol Oncol; 2017 Mar; 10(1):79. PubMed ID: 28356122
[TBL] [Abstract][Full Text] [Related]
27. A five-miRNA expression signature predicts survival in hepatocellular carcinoma.
Liu G; Wang H; Fu JD; Liu JY; Yan AG; Guan YY
APMIS; 2017 Jul; 125(7):614-622. PubMed ID: 28430373
[TBL] [Abstract][Full Text] [Related]
28. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma.
Miao YD; Kou ZY; Wang JT; Mi DH
World J Clin Cases; 2021 Oct; 9(29):8671-8693. PubMed ID: 34734046
[TBL] [Abstract][Full Text] [Related]
29. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
Jin L; Li C; Liu T; Wang L
Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-1249 targets four-jointed box kinase 1 and reduces cell proliferation, migration and invasion of colon adenocarcinoma.
Dang W; Zhu Z
J Gene Med; 2020 Jul; 22(7):e3183. PubMed ID: 32159255
[TBL] [Abstract][Full Text] [Related]
31. 5mC-Related lncRNAs as Potential Prognostic Biomarkers in Colon Adenocarcinoma.
Huang Y; Huang H; Wang Y; Liu H; Huang Y
Biology (Basel); 2022 Feb; 11(2):. PubMed ID: 35205097
[TBL] [Abstract][Full Text] [Related]
32. A 4-microRNA signature for survival prognosis in pediatric and adolescent acute myeloid leukemia.
Zhu R; Lin W; Zhao W; Fan F; Tang L; Hu Y
J Cell Biochem; 2019 Mar; 120(3):3958-3968. PubMed ID: 30242879
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the Role and Regulatory Mechanism of hsa-miR-504 in Cervical Cancer Based on The Cancer Genome Atlas Database.
Li D; Liu SH; Liu QY; Zou QQ; Lv L; Liu GL; Wu Y
Cancer Biother Radiopharm; 2021 Aug; 36(6):511-520. PubMed ID: 32589477
[No Abstract] [Full Text] [Related]
35. Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma.
Liao X; Zhu G; Huang R; Yang C; Wang X; Huang K; Yu T; Han C; Su H; Peng T
Cancer Manag Res; 2018; 10():787-803. PubMed ID: 29713196
[TBL] [Abstract][Full Text] [Related]
36. Development of a 21-miRNA Signature Associated With the Prognosis of Patients With Bladder Cancer.
Yin XH; Jin YH; Cao Y; Wong Y; Weng H; Sun C; Deng JH; Zeng XT
Front Oncol; 2019; 9():729. PubMed ID: 31448232
[No Abstract] [Full Text] [Related]
37. A P53-related microRNA model for predicting the prognosis of hepatocellular carcinoma patients.
Fang SS; Guo JC; Zhang JH; Liu JN; Hong S; Yu B; Gao Y; Hu SP; Liu HZ; Sun L; Zhao Y
J Cell Physiol; 2020 Apr; 235(4):3569-3578. PubMed ID: 31556110
[TBL] [Abstract][Full Text] [Related]
38. Identification of Transcription Factor-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma.
Lin J; Cao Z; Yu D; Cai W
Front Genet; 2021; 12():709133. PubMed ID: 34603375
[TBL] [Abstract][Full Text] [Related]
39. Construction of a miRNA Signature Using Support Vector Machine to Identify Microsatellite Instability Status and Prognosis in Gastric Cancer.
Wang YN; Wei YN; Fan XY; Xu F; Dong ZY; Cheng SJ; Zhang JK
J Oncol; 2022; 2022():6586354. PubMed ID: 35466315
[TBL] [Abstract][Full Text] [Related]
40. A Competing Endogenous RNA Network Reveals Novel Potential lncRNA, miRNA, and mRNA Biomarkers in the Prognosis of Human Colon Adenocarcinoma.
Wang WJ; Li HT; Yu JP; Han XP; Xu ZP; Li YM; Jiao ZY; Liu HB
J Surg Res; 2019 Mar; 235():22-33. PubMed ID: 30691798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
